Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus

about

Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus

Item

http://www.wikidata.org/entity/Q58737185

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@en

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@nl

type

Item

label

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@en

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@nl

prefLabel

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@en

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@nl

P1476

Effects of glucagon-like pepti ...... with type 2 diabetes mellitus

@en

P2093

Alekber A Bayramov

http://www.w3.org/2001/XMLSchema#string

Alina Y Babenko

http://www.w3.org/2001/XMLSchema#string

Denis A Lebedev

http://www.w3.org/2001/XMLSchema#string

Elena N Grineva

http://www.w3.org/2001/XMLSchema#string

Elvira V Kuleshova

http://www.w3.org/2001/XMLSchema#string

Irina B Krylova

http://www.w3.org/2001/XMLSchema#string

Michael M Galagudza

http://www.w3.org/2001/XMLSchema#string

Taisiia P Tuchina

http://www.w3.org/2001/XMLSchema#string

Vladislav A Zykov

http://www.w3.org/2001/XMLSchema#string

P2860

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

Effects of Moderate Glycemic Control in Type II Diabetes With Insulin on Arterial Blood Gas Parameters Following Coronary Artery Bypass Graft Surgery.

Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice

Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes

The role of GLP-1 in the regulation of islet cell mass.

GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.

Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction

The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus.

GLP-1 receptor agonists: effects on cardiovascular risk reduction.

P304

149-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4239/WJD.V9.I9.149

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30254724

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

6153122

http://www.w3.org/2001/XMLSchema#string